| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer | Oncology Reports | 2015 | 654 |
| 2 | Non-coding RNAs as regulators in epigenetics | Oncology Reports | 2017 | 527 |
| 3 | Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo | Oncology Reports | 2017 | 384 |
| 4 | Cancer drug delivery in the nano era: An overview and perspectives | Oncology Reports | 2017 | 330 |
| 5 | Role of the tumor microenvironment in tumor progression and the clinical applications (Review) | Oncology Reports | 2016 | 268 |
| 6 | microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN | Oncology Reports | 2012 | 262 |
| 7 | Genetics, diagnosis and management of colorectal cancer (Review) | Oncology Reports | 2015 | 256 |
| 8 | Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: A clinical and in vitro investigation | Oncology Reports | 2014 | 246 |
| 9 | Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines | Oncology Reports | 2012 | 221 |
| 10 | Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma | Oncology Reports | 2013 | 219 |
| 11 | Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. | Oncology Reports | 2000 | 216 |
| 12 | Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). | Oncology Reports | 1998 | 215 |
| 13 | Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function | Oncology Reports | 2015 | 210 |
| 14 | Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer | Oncology Reports | 2014 | 200 |
| 15 | Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis | Oncology Reports | 2017 | 200 |
| 16 | Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization | Oncology Reports | 2017 | 199 |
| 17 | MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2 | Oncology Reports | 2010 | 193 |
| 18 | The emerging landscape of circular RNA ciRS-7 in cancer (Review) | Oncology Reports | 2015 | 193 |
| 19 | Patterns of MMP-2 and MMP-9 expression in human cancer cell lines | Oncology Reports | 2009 | 190 |
| 20 | Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation | Oncology Reports | 2013 | 187 |
| 21 | Diverse roles of miR-29 in cancer (Review) | Oncology Reports | 2014 | 187 |
| 22 | Cisplatin and platinum drugs at the molecular level (Review) | Oncology Reports | 2003 | 185 |
| 23 | Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway | Oncology Reports | 2015 | 175 |
| 24 | Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2 | Oncology Reports | 2017 | 171 |
| 25 | Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer | Oncology Reports | 2018 | 169 |
| 26 | miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells | Oncology Reports | 2013 | 162 |
| 27 | Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. | Oncology Reports | 2000 | 157 |
| 28 | Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). | Oncology Reports | 1998 | 154 |
| 29 | Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer | Oncology Reports | 2014 | 154 |
| 30 | Comparative genomics on Fgf11 orthologs. | Oncology Reports | 2005 | 152 |
| 31 | miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect | Oncology Reports | 2012 | 150 |
| 32 | Downregulated microRNA-200a promotes EMT and tumor growth through the Wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma | Oncology Reports | 2013 | 148 |
| 33 | Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study. | Oncology Reports | 2000 | 146 |
| 34 | Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity | Oncology Reports | 2011 | 146 |
| 35 | Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review) | Oncology Reports | 2014 | 146 |
| 36 | microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2 | Oncology Reports | 2010 | 145 |
| 37 | microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers | Oncology Reports | 2013 | 145 |
| 38 | Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma | Oncology Reports | 2015 | 145 |
| 39 | Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. | Oncology Reports | 1999 | 144 |
| 40 | Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition | Oncology Reports | 2016 | 144 |
| 41 | Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (Review) | Oncology Reports | 2005 | 143 |
| 42 | Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer | Oncology Reports | 2012 | 143 |
| 43 | Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells | Oncology Reports | 2016 | 143 |
| 44 | (−)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells | Oncology Reports | 2015 | 142 |
| 45 | ARID1A gene mutation in ovarian and endometrial cancers (Review) | Oncology Reports | 2016 | 142 |
| 46 | WNT/PCP signaling pathway and human cancer (Review) | Oncology Reports | 2005 | 140 |
| 47 | H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells | Oncology Reports | 2015 | 139 |
| 48 | Chemotherapy for breast cancer (Review) | Oncology Reports | 2010 | 138 |
| 49 | FTO expression is associated with the occurrence of gastric cancer and prognosis | Oncology Reports | 2017 | 138 |
| 50 | Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway | Oncology Reports | 2010 | 135 |
